Autopsy report · NCT01759784

Intraventricular Transplantation of Mesenchymal Stem Cell in Patients With ALS

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.

“The stereotaxis can be threatful for the patients because of respiratory insufficiency”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: Royan Institute
Sponsor type: Government (non-US federal)
Conditions: Amyotrophic Lateral Sclerosis
Interventions: Intraventricular injection
Participants: 0
Sites: 1
Countries: Iran

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.